• Protein S Activity
  • Prader-Willi and Angelman Syndrome Molecular Analysis
  • Low-Grade Fibromyxoid Sarcoma (LGFMS), 16p11 (FUS or TLS) Rearrangement, FISH, Tissue
  • Triiodothyronine (T3), Reverse
  • Giardia Species by PCR, Stool
  • Nordoxepin, Urine
  • Cephalosporin IgE
  • Cryptococcus Antigen, Pleural Fluid
  • Chromosome Analysis, Hematologic Disorders, Bone Marrow
  • Fructosamine (Glycated Protein)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

ICD10
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.
Loading...